Cabot (NYSE:CBT) Reaches New 52-Week Low - Should You Sell?

Key Points

• Cabot Corporation's stock reached a new 52-week low of $70.37, down from a previous close of $71.24, with 63,212 shares traded.
• Analysts have set a consensus target price of $85.00 for Cabot stock, with ratings ranging from Buy to Hold.
• CEO Sean D. Keohane sold over 114,000 shares of Cabot stock, reducing his ownership by 24.04% amid notable recent institutional investments.

Cabot Corporation (NYSE:CBT - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $70.37 and last traded at $70.45, with a volume of 63212 shares traded. The stock had previously closed at $71.24.

Analysts Set New Price Targets

Several research analysts have issued reports on the stock. UBS Group set a $82.00 price objective on shares of Cabot and gave the stock a "neutral" rating in a research report on Tuesday, August 5th. Mizuho lowered their target price on shares of Cabot from $90.00 to $88.00 and set an "outperform" rating on the stock in a report on Friday, October 3rd. Finally, Weiss Ratings reaffirmed a "hold (c)" rating on shares of Cabot in a report on Wednesday. One equities research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company has an average rating of "Hold" and a consensus target price of $85.00.

Cabot Stock Performance

The stock's 50-day moving average is $78.19 and its 200-day moving average is $77.33. The stock has a market cap of $3.74 billion, a price-to-earnings ratio of 9.20 and a beta of 0.88. The company has a debt-to-equity ratio of 0.66, a current ratio of 2.13 and a quick ratio of 1.41.

Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 4th. The specialty chemicals company reported $1.90 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.80 by $0.10. Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm had revenue of $923.00 million for the quarter, compared to analyst estimates of $957.29 million. Cabot has set its FY 2025 guidance at 7.150-7.500 EPS. Analysts anticipate that Cabot Corporation will post 7.57 EPS for the current fiscal year.

Insider Transactions at Cabot

In related news, CEO Sean D. Keohane sold 114,436 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $79.28, for a total value of $9,072,486.08. Following the completion of the sale, the chief executive officer directly owned 361,518 shares in the company, valued at approximately $28,661,147.04. The trade was a 24.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 3.03% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. QRG Capital Management Inc. bought a new position in Cabot during the 1st quarter valued at $482,000. SG Americas Securities LLC acquired a new stake in shares of Cabot during the first quarter worth $1,102,000. GAMMA Investing LLC raised its holdings in shares of Cabot by 26.1% during the first quarter. GAMMA Investing LLC now owns 1,700 shares of the specialty chemicals company's stock worth $141,000 after purchasing an additional 352 shares during the period. KBC Group NV raised its holdings in shares of Cabot by 31.5% during the first quarter. KBC Group NV now owns 2,690 shares of the specialty chemicals company's stock worth $224,000 after purchasing an additional 644 shares during the period. Finally, Janney Montgomery Scott LLC acquired a new stake in shares of Cabot during the first quarter worth $975,000. 93.18% of the stock is currently owned by hedge funds and other institutional investors.

Cabot Company Profile

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.